Experimental validation of serum Clara cell protein (CC16) as a marker of the broncho-alveolar blood barrier permeability during acute lung injury.

Hermans, C.; Knoops, Bernard; Arsalane, K.; Wiedig, C.; Toubeau, G.

Experimental validation of serum Clara cell protein (CC16) as a marker of the broncho-alveolar blood barrier permeability during acute lung injury.

Hermans, C.

;

Knoops, Bernard

;

Arsalane, K.

;

Wiedig, C.

;

Toubeau, G.

(1997) ERS Annual Congress — Location: Berlin, Germany (20.September.1997)

Files

No attached file found for this publication.

Details

Authors

Hermans, C.UCLouvain
Author
Knoops, BernardUCLouvain
Author
Arsalane, K.-
Author
Wiedig, C.UCLouvain
Author
Toubeau, G.UCLouvain
Author

Affiliations

UCLouvainSST/ISV - Institut des sciences de la vie
UCLouvainSST/LIBST - Louvain Institute of Biomolecular Science and Technology

Citations

APA
Chicago
FWB

Hermans, C., Knoops, B., Arsalane, K., Wiedig, C., & Toubeau, G. (1997). Experimental validation of serum Clara cell protein (CC16) as a marker of the broncho-alveolar blood barrier permeability during acute lung injury. European Respiratory Journal. Supplement, 10(25), 478s. https://hdl.handle.net/2078.5/181864 (Original work published 1997)